TELA Bio (TELA) Cash from Operations Growth (3y) (2021 - 2026)
Powered by 
Analysis
TELA Bio (TELA) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | 27.41% |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | 16.81% |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 27.02% |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 22.38% |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 30.85% |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | 168.71% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | 16.21% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 12.26% |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 9.30% |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | 5.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.92% |
| Mar 31, 2026 | 1.18% |
| Dec 31, 2025 | 23.74% |
| Sep 30, 2025 | 9.24% |
| Jun 30, 2025 | 12.22% |
| Mar 31, 2025 | 2.31% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | -10.65% |
| Jun 30, 2024 | -23.86% |
| Mar 31, 2024 | -18.77% |
| Dec 31, 2023 | -15.87% |
| Sep 30, 2023 | -23.60% |
| Jun 30, 2023 | -21.02% |
| Mar 31, 2023 | -16.57% |
| Dec 31, 2022 | -15.20% |
| Sep 30, 2022 | -12.61% |
| Jun 30, 2022 | -30.94% |
| Mar 31, 2022 | -10.28% |
| Dec 31, 2021 | -18.49% |